IGI Logo
Toggle Navigation
News
Hindi
Hindi News
Top News
Screeners
Stocks
Stocks Screener
Stock
News
Stock Market Home Page
Stock News
Industry News
Economy News
Stock on the move
Expert Views
Research Reports
Company Result
Comp Info And Fundamentals
Company Profile
Equity
Financial Ratios
Results
Balance Sheet
Profit And Loss
Cash Flow
Share Holding
Derivatives (F&O)
Get Quotes
Market Watch
Top Gainers
Top Losers
Top Traded Quantity
Top Traded Value
Most Active Puts
Derivatives (F&O)
Most Active Calls
Put Call Ratio
Highest In Premium
Daily Settlement Price
FII and DII Statistics
Open Interest: Highest In OI
Open Interest: Lowest In OI
Derivatives (F&O)
Open Interest: Increase in OI Increase in Price
Open Interest: Decline in OI Decrease in Price
Derivative Watch
Derivatives Dashboard
Historical Data
List of Underlyings & Underlying Info
Derivative Watch
Derivatives Dashboard
Market Reports
Top Gainers
Top Losers
Monthly High/Low
52 Week High
52 Week Low
Market Cap Gainers
Market Cap Losers
PE Ratio
>More Market Reports
IPO
News
IPO News
IPO Issue Reports
Commodity
Commodity Market
Commodity Home Page
Commodity News
Commodity Reports
Market Details
Get Quotes
Top Gainers
Top Losers
Top Volume
Top Value
Top Gainers Spot Market
Top Losers Spot Market
High & Low
Commodity Indices
Technical Analysis
Advance Declines
High & Low
Highest In OI
Lowest OI
Increase In Open Interest(%)
Descrease In Open Interest(%)
Currency
News
Currency News
Economy News
Currency Reports
Mutual Fund
News
Mutual Fund Home Page
Mutual Fund News
Mutual Fund Details
Mutual Fund Home Page
Compare Scheme
Scheme Profile
Mutual fund Investment
Mutual Fund Share Holding
Mutual Fund Statistics
Mutual fund Gainers
Mutual fund Losers
Biggest Schemes
Best Performers
Latest Dividend Details
Tools
Multi Scheme Comparison Tool
Dividend Details
Performance Map
Mutual fund Investment
Mutual fund Share Holding
Mutual Fund Search Category Rankings
Widgets
Stock Widgets
Watchlist
Heatmap
Mutual Fund Widgets
Watchlist
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
Wealth
World
Tips
Intraday Tips
Market Outlook
Stock Tips
Commodity Tips
Currency Tips
Reports
Short Term Investment Opportunities
Long Term Investment Opportunities
Sector Analysis
Commodity Reports
Currency Reports
Mutual Fund Analysis
Podcast
Videos
Videos Category
Business Videos
Budget Videos
News And Politics
Entertainment Videos
Sports Videos
Lifestyle And Fashion Videos
Global News Videos
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
More
Budget 2024
Astrology
Women
Politics
Entertainment
Car&Bike
Gadgets
Lifestyle
Sports
Health
Fashion
Diwali Reports
Diwali Expert Reports
News
Astrology
Beyond Market Car
Beyond Market Entertainment
Beyond Market Fashion
Beyond Market Gadgets
Beyond Market Health
Beyond Market India
Beyond Market Life Style
Beyond Market Sports
Broking Firm Views
Broking Firm Views - Long Term Report
Broking Firm Views - Sector Report
Broking Firm Views - Short Term Report
Budget 2024 Sector Reports
Budget Bites
Budget Economic Servey
Budget Expert Views
Budget Industry
Budget News
Budget Wishlist
Commodities
Commodities Reports
Commodity Top News
Company News
Company Result
Currency News
Currency Report
Currency Top News
Diwali Expert Views
Diwali Market Outlook
Diwali Report
Diwali Technical Report
Economy News
Expert View Institution
Expert Views
Industry News
IPO Analysis
IPO More News
IPO Reports
IPO Top News
Market Outlook
Mutual Fund Analysis
Mutual Fund Expert Views
Mutual Fund More News
Mutual Fund Top News
Podcast - Market Ki Awaaz
Special Event Expert Views
Special Event Reports
Startup
Startup Expections
Startup Speak
Stock Market
Stock On The Move
Top News
Top Stories
Videos
Videos Business
Videos Entertainment
Videos Global News
Videos Lifestyle And Fashion
Videos News And Politics
Videos Sports
Wealth
Women
World Market More News
World Top News
Search
Aster DM’s 1Q Revenue/EBITDA was ahead of JMFe primarily driven by strong GCC performance. Reported PAT was lower than estimates due to one-time tax charge of INR 443mn and new hospital losses of INR 230mn adjusted for which PAT grew 87%YoY. GCC hospital revenues grew 19%YoY with c. 15.6% margin (17% adj. for new hospital losses). The India Hospital revenues (6% beat) was driven by strong ARPOB growth due to price hikes, better case mix and higher cash patients which is expected to sust...
Buy Aster DM Healthcare Ltd For Target Rs. 335 - JM Financial Institutional Securities
Aster DM Healthcare is currently trading at Rs. 302.35, up by 0.30 points or 0.10% from its previous closing of Rs. 302.05 on the BSE. The scrip opened at Rs. 302.25 and has touched a high and low of Rs. 307.35 and Rs. 301.45 respectively. So far 7247 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 336.40 on 04-Jul-2023 and a 52 week low of Rs. 193.80 on 14-Jul-2022. Last one week high and low of the scrip stoo...
Aster DM Healthcare rises as its arm acquires remaining 20% stake in Premium Healthcare
Aster DM Healthcare is currently trading at Rs. 320.55, up by 9.75 points or 3.14% from its previous closing of Rs. 310.80 on the BSE. The scrip opened at Rs. 314.00 and has touched a high and low of Rs. 327.95 and Rs. 314.00 respectively. So far 67966 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 336.40 on 04-Jul-2023 and a 52 week low of Rs. 181.80 on 07-Jul-2022. Last one week high and low of the scrip sto...
Aster DM Healthcare jumps on acquiring additional 2.36% stake in Malabar Institute of Medical Sciences
India outperformance to continue Aster DM’s 4Q Revenue/EBITDA was broadly in-line with JMFe driven by better India hospitals, GCC clinics and GCC pharmacies performance. However, PAT missed estimates by 9% due to lower other income, higher finance costs and depreciation. GCC hospital revenues grew 15%YoY with 13.7% margin (17% adj. for new hospital losses). India hospitals beat estimates yet again with 15.8% EBITDAM (JMFe: 15%), lower due to Aster Lab losses. We expect Indi...
Buy Aster DM Healthcare Ltd For Target Rs. 300 - JM Financial Institutional Securities
Aster DM Healthcare is currently trading at Rs. 271.70, up by 1.15 points or 0.43% from its previous closing of Rs. 270.55 on the BSE. The scrip opened at Rs. 272.95 and has touched a high and low of Rs. 276.15 and Rs. 266.85 respectively. So far 22406 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 285.00 on 25-May-2023 and a 52 week low of Rs. 168.35 on 20-Jun-2022. Last one week high and low of the scrip sto...
Aster DM Healthcare rises on inking pact with Padmavathy Medical Foundation
Aster DM Healthcare is currently trading at Rs. 231.50, up by 0.35 points or 0.15% from its previous closing of Rs. 231.15 on the BSE. The scrip opened at Rs. 231.15 and has touched a high and low of Rs. 233.45 and Rs. 231.00 respectively. So far 629 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 275.45 on 04-Nov-2022 and a 52 week low of Rs. 162.65 on 12-May-2022. Last one week high and low of the scrip stood...
Aster DM Healthcare inches up as its arm incorporates Joint Venture Company in Riyadh
Growth driven by GCC hospitals and pharmacies Aster DM Healthcare’s (Aster) Q3FY23 performance exceeded our expectations on revenue front, largely driven by strong growth in GCC hospitals and pharmacies. Consolidated revenue grew 20.5% YoY to Rs31.9bn (I-Sec: Rs28.1bn). GCC hospitals posted healthy growth of 22% YoY. India hospitals revenue was up 18.9% YoY (-5.5% QoQ). EBITDA margin contracted 90bps YoY to 14.1% (I-Sec:14%). We expect overall business and margins to improve with hig...
Buy Aster DM Healthcare Ltd For Target Rs. 262 - ICICI Securities
India business sustains growth momentum Aster DM’s 3Q was ahead of our estimates driven by better India hospitals, GCC clinics and GCC pharmacies performance. GCC hospital revenues grew 22%YoY with 16.1% margin (18% adj. for new hospital losses). India hospitals beat estimates yet again with 15.7% EBITDAM (JMFe: 17%), lower due to Aster Lab losses. The management expects India business to continue momentum as: (1) Kerala cluster has been operating at 80%+ occupancies; (2) AP-Telangan...
Buy Aster DM Healthcare Ltd For Target Rs. 260 - JM Financial Institutional Securities
Aster DM Healthcare is currently trading at Rs. 223.30, up by 1.40 points or 0.63% from its previous closing of Rs. 221.90 on the BSE. The scrip opened at Rs. 221.90 and has touched a high and low of Rs. 224.50 and Rs. 218.50 respectively. So far 5411 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 275.45 on 04-Nov-2022 and a 52 week low of Rs. 158.00 on 07-Mar-2022. Last one week high and low of the scrip stoo...
Aster DM Healthcare gains as its arm to acquire 99.99% stake in Cantown Infra Developers
Aster DM Healthcare is currently trading at Rs. 232.00, up by 1.55 points or 0.67% from its previous closing of Rs. 230.45 on the BSE. The scrip opened at Rs. 228.30 and has touched a high and low of Rs. 234.75 and Rs. 228.30 respectively. So far 15578 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 275.45 on 04-Nov-2022 and a 52 week low of Rs. 158.00 on 07-Mar-2022. Last one week high and low of the scrip sto...
Aster DM Healthcare gains as its arm to acquire 100% stake in Adiran IB Healthcare
GCC clinics, new hospitals dent margins; India margins upbeat… About the stock: Aster operates a network of hospitals, clinics, retail pharmacies in several GCC countries as well as India. * Its network consists of 15 hospitals, 110 clinics and 245 retail pharmacies in GCC states;15 hospitals, 11 clinics and 159 labs in India; total bed capacity: GCC: 1160, India: 3905 * Revenue break-up FY22: hospitals: 56%, pharmacies: 21%, clinics: 23% with GCC & India contributing 77% ...
Buy Aster DM Healthcare Ltd For Target Rs.300 - ICICI Direct
Aster DM Healthcare is currently trading at Rs. 233.00, up by 5.75 points or 2.53% from its previous closing of Rs. 227.25 on the BSE. The scrip opened at Rs. 231.80 and has touched a high and low of Rs. 235.15 and Rs. 227.50 respectively. So far 26958 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 275.45 on 04-Nov-2022 and a 52 week low of Rs. 158.00 on 07-Mar-2022. Last one week high and low of the scrip sto...
Aster DM Healthcare zooms on signing contract with Faruk Medical City
GCC clinics, new hospitals dent margins; India margins upbeat… About the stock: Aster operates a network of hospitals, clinics, retail pharmacies in several GCC countries as well as India. * Its network consists of 15 hospitals, 110 clinics and 245 retail pharmacies in GCC states;15 hospitals, 11 clinics and 159 labs in India; total bed capacity: GCC: 1160, India: 3905 * Revenue break-up FY22: hospitals: 56%, pharmacies: 21%, clinics: 23% with GCC & India contributing 77% ...
Buy Aster DM Healthcare Ltd For Target Rs. 300 - ICICI Direct
Aster DM Healthcare Ltd TECHNICAL RATIONALE ATERDM has retraced marginally of late on low volumes, after making a new record high at 275.60. Technically, it’s an healthy pause in a strong uptrend and we thus recommend utilizing this buying opportunity and initiate fresh longs as per the mentioned levels. Buy Aster DM Healthcare Ltd @263-266 CMP 266.50 Stop Loss 249 Target 289 Muthoot Finance Ltd TECHNICAL RATIONALE After spending almost 6 m...
Tech Stars - Aster DM Healthcare Ltd and Muthoot Finance Ltd By Religare Broking
Aster DM Healthcare is currently trading at Rs 249.65, up by 7.35 points or 3.03% from its previous closing of Rs. 242.30 on the BSE. The scrip opened at Rs. 247.05 and has touched a high and low of Rs. 251.60 and Rs. 247.05 respectively. So far 39024 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 265.55 on 11-Oct-2022 and a 52 week low of Rs. 158.00 on 07-Mar-2022. Last one week high and low of the scrip stoo...
Aster DM Healthcare surges as its arm enters into JVA with Abdulmohsen Al Hokair Holding Group
Aster DM Healthcare is currently trading at Rs. 248.85, up by 0.85 points or 0.34% from its previous closing of Rs. 248.00 on the BSE. The scrip opened at Rs. 250.15 and has touched a high and low of Rs. 253.15 and Rs. 245.30 respectively. So far 28294 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 265.55 on 08-Sep-2022 and a 52 week low of Rs. 158.00 on 07-Mar-2022. Last one week high and low of the scrip sto...
Aster DM Healthcare rises as its arm acquires additional 2% stake in Medcare Hospital
Aster DM Healthcare is currently trading at Rs. 222.60, up by 7.10 points or 3.29% from its previous closing of Rs. 215.50 on the BSE. The scrip opened at Rs. 211.00 and has touched a high and low of Rs. 228.95 and Rs. 209.50 respectively. So far 52575 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 244.10 on 02-Aug-2022 and a 52 week low of Rs. 158.00 on 07-Mar-2022. Last one week high and low of the scrip sto...
Aster DM Healthcare soars as its arm executes area development agreement with GD Assist
Aster DM Healthcare is currently trading at Rs. 190.00, up by 0.65 points or 0.34% from its previous closing of Rs. 189.35 on the BSE. The scrip opened at Rs. 188.40 and has touched a high and low of Rs. 192.00 and Rs. 188.40 respectively. So far 177 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 237.25 on 14-Sep-2021 and a 52 week low of Rs. 147.00 on 09-Jun-2021. Last one week high and low of the scrip stood...
Aster DM Healthcare rises on commencing drone delivery trials with Skye Air Mobility in Kerala
The company reported standalone net profit during the quarter stood at Rs 62.87 crore compared to net loss of Rs 14.24 crore in the previous year quarter. Net revenue of the company rose substantially by 24.04 per cent at Rs 290.79 crore in January-March quarter of this fiscal as against Rs 234.43 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 10.47 per cent to Rs 246.79 crore from Rs 223.41 crore in year ago period. Other Income gre...
Aster DM Healthcare posts Q4 net profit of Rs 62.87 cr
Normalcy in India, GCC; focus on India expansion… About the stock: Aster operates in segments like hospitals, clinics, retail pharmacies and provides healthcare services to patients across economic segments in several GCC states through various brands such as Aster, Medcare and Access. Its network consists of 13 hospitals, 109 clinics and 233 retail pharmacies in the GCC states;14 hospitals, nine clinics, 90 pharmacies and 66 labs in India; total bed capacity: GCC: 1160, India: 3...
Buy Aster DM Healthcare Ltd For Target Rs. 250 - ICICI Direct
Aster DM Healthcare is currently trading at Rs. 185.05, up by 4.65 points or 2.58% from its previous closing of Rs. 180.40 on the BSE. The scrip opened at Rs. 182.40 and has touched a high and low of Rs. 186.25 and Rs. 182.30 respectively. So far 5679 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 237.25 on 14-Sep-2021 and a 52 week low of Rs. 132.55 on 26-Mar-2021. Last one week high and low of the scrip stoo...
Aster DM Healthcare shines on signing MoU with Government of Tamil Nadu
Strong domestic performance drives Q3 Aster DM Healthcare’s (Aster) Q3FY22 performance exceeded our estimates mainly due to better than expected growth in India hospitals. Consolidated revenues grew 18.9% YoY to Rs26.5bn (I-Sec: Rs25.0bn), which works out to a 2- year CAGR of 6.8%. EBITDA margin improved by 30bps YoY to 15.0% with occupancy recovery. We expect the overall business and margins to continue improving with higher occupancy and case mix. We believe the company’s str...
Add Aster DM Healthcare Ltd For Target Rs. 211 - ICICI Securities
Shifting focus to India biz Aster’s 3QFY22 beat expectations on the back of third consecutive quarter of India outperformance as the company shifts focus to India. Revenue/ EBITDA/ PAT of INR 26496 mn/ 3971 mn/ 1483 mn were +19%/+21%/+61% YoY and were +8%/+3%/+7% vs. our estimates. EBITDA margin improved by c.30 bps YoY to 15% (JMFe: 15.6%). India hospitals Revenue/ EBITDA of INR 6180 mn/ 1040 mn delivered a meaningful beat (+55%/+145%) as capacities continue to ramp up with over 60 ...
Buy Aster DM Healthcare Ltd For Target Rs. 290 - JM Financial Services
Buy Aster DM Healthcare Ltd For Target Rs.193 Strong recovery; agressive focus on India Aster DM Healthcare’s (Aster) Q1FY22 performance was broadly in-line with our estimates with strong recovery across GCC and India businesses. Occupancy improved by 700bps QoQ to 65% during Q1FY22. Consolidated revenue grew 35.7% YoY to Rs23.7bn (I-Sec: Rs22.9bn), 2-year CAGR of 8.1%. EBITDA margin improved 360bps YoY to 11.8% (I-Sec:12.0%) with occupancy recovery and on a low base. We expect...
Buy Aster DM Healthcare Ltd : Strong recovery; agressive focus on India - ICICI Securities
India recovers; GCC recovery remains slow Aster DM Healthcare’s (Aster) Q4FY21 performance was broadly inline with our estimates, though margin was lower due to higher S,G&A expenses, particularly related to COVID-19 patients which would normalise. Overall occupancy improved marginally YoY and QoQ to 58% during Q4FY21. Consolidated revenue grew 4.8% YoY to Rs23.9bn (I-Sec: Rs23.2bn), India hospitals witnessed healthy recovery with 19.7% YoY growth. EBITDA margin declined 370bps Y...
Buy Aster DM Healthcare Ltd For Target Rs. 193 - ICICI Securities
Aster DM Healthcare is currently trading at Rs. 152.40, down by 5.80 points or 3.67% from its previous closing of Rs. 158.20 on the BSE. The scrip opened at Rs. 154.00 and has touched a high and low of Rs. 154.50 and Rs. 151.00 respectively. So far 94233 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 179.90 on 20-Nov-2020 and a 52 week low of Rs. 119.40 on 14-Jul-2020. Last one week high and low of the scrip s...
Aster DM Healthcare trades in red on reporting 20% fall in Q4 consolidated net profit
Our Take: Aster DM Healthcare Ltd has a unique business model among Indian healthcare service providers with a strong established presence in GCC (Gulf Cooperation council) and India. While the India expansion remains on an investment curve, a firm presence in GCC helps the company in pursuing aggressive expansion in both GCC and India albeit via an asset light model. The company has a diversified portfolio of healthcare facilities, consisting of 26 hospitals (bed capacity 4873), 115 cl...
Update On Aster DM Healthcare By HDFC Securities
Second wave impacts GCC, India back to near normal Q3 revenues stayed flat QoQ at | 2259 crore (still down 2.7% YoY) vs. | 2268 crore in the last quarter. India revenues grew 10.8% QoQ (up 6.7% YoY) to | 460 crore. However, GCC revenues de-grew 3.4% QoQ (down 4.6% YoY) to | 1866 crore. EBITDA margins expanded 257 bps QoQ to 14.5% due to lower other expenditure. Subsequent EBITDA grew 21.0% QoQ to | 328 crore. PAT came in at | 92 crore, which is ~2.8x of last quarter. Strong R...
Buy Aster DM Healthcare Ltd For Target Rs.210 - ICICI Direct
India recovers; GCC recovery remains slow Aster DM Healthcare’s (Aster) Q3FY21 performance was below our estimates due to weak growth in GCC hospitals. Overall occupancy remained flat YoY and QoQ at 57% during Q3FY21. Consolidated revenue declined 2.7% YoY to Rs22.6bn (ISec: Rs23.8bn), India hospitals witnessed healthy recovery with 7.7% YoY growth. EBITDA margin declined 210bps YoY to 14.5% (I-Sec:15.0%) on a high base. We expect overall business to stabilise by Q1FY22 and expect s...
Buy Aster DM Healthcare Ltd For Target Rs.200 - ICICI Securities
Load More